| Title : Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients - Duflot_2019_Cardiovasc.Diabetol_18_35 |
| Author(s) : Duflot T , Moreau-Grange L , Roche C , Iacob M , Wils J , Remy-Jouet I , Cailleux AF , Leuillier M , Renet S , Li D , Morisseau C , Lamoureux F , Richard V , Prevost G , Joannides R , Bellien J |
| Ref : Cardiovasc Diabetol , 18 :35 , 2019 |
| Abstract : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| ESTHER : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| PubMedSearch : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| PubMedID: 30885203 |
| Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J |
| Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015 |
| Abstract : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| ESTHER : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| PubMedID: 25724490 |
| Title : Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice - Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| Author(s) : Roche C , Guerrot D , Harouki N , Duflot T , Besnier M , Remy-Jouet I , Renet S , Dumesnil A , Lejeune A , Morisseau C , Richard V , Bellien J |
| Ref : Prostaglandins Other Lipid Mediat , 120 :148 , 2015 |
| Abstract : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| ESTHER : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| PubMedSearch : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| PubMedID: 26022136 |